Page 48 - TD-1-2

Tumor Discovery Benefits and harms of screening breast cancer

be financially responsible for the application of medical 4. Gøtzsche PC, Nielsen M. 2006, Screening for breast cancer
procedures that are not based on scientific evidence. with mammography. Cochrane Database Syst Rev, 2006(4):
CD001877.
Acknowledgments https://doi.org/10.1002/14651858.CD001877.pub2

Refer to primary version. 5. Bleyer A, Welch G. 2012, Effect of three decades of screening
mammography on breast-cancer incidence. N Engl J Med,
Funding 367(21): 1998–2005.
Refer to primary version. https://doi.org/10.1056/NEJMoa1206809
Conflict of interest 6. National Breast Cancer Coalition. 2011, Mammography
for Breast Cancer Screening: Harm/Benefit Analysis.
Refer to primary version. Washington, D.C: National Breast Cancer Coalition.
Author contributions https://doi.org/www.breastcancerdeadline2020.org/breast-
cancer-information/breast-cancer-information-and-
Refer to primary version. positions/mammography-for-breast-cancer.pdf

Ethics approval and consent to participate 7. Gøtzsche PC, Jørgensen KJ. 2013, Screening for breast
cancer with mammography. Cochrane Database Syst Rev, 6:
Refer to primary version. CD001877.

Consent for publication 8. Gøtzsche PC. 2012, Mammography Screening: Truth, Lies
and Controversy. London: Radcliffe Publishing.
Refer to primary version.
9. Jørgensen KJ, Keen JD, Gøtzsche PC. 2011, Is mammographic
Availability of data screening justifiable considering its substantial overdiagnosis
rate and minor effect on mortality? Radiology, 260(3): 621–626.
Refer to primary version.
https://doi.org/10.1148/radiol.11110210
Editorial disclosure 10. Biller-Andorno N, Jüni P. 2014, Abolishing mammography
The paper, after translation, has been edited to adapt it to screening programs? A view from the Swiss Medical Board.
N Engl J Med, 370(21): 1965–1967.
the format and style of Tumor Discovery. The most obvious
change to the paper is the removal of Summary section https://doi.org/10.1056/NEJMp1401875
(“Resumen” in original). 11. Gøtzsche PC, Harting OJ, Nielsen M, et al. 2012, La
mamografía como método de cribado para detectar el
References cáncer de mama. Centro Nórdico Cochrane. Available from:
1. Sackett DL, Holland WW. 1975, Controversy in the detection https://nordic.cochrane.org/sites/nordic.cochrane.org/files/
of disease. Lancet, 2(7930): 357–359. public/uploads/images/mammography/mamografia-es.pdf
https://doi.org/10.1016/s0140-6736(75)92790-7 12. Prasad V, Lenzer J, Newman DH. 2016, Why cancer
screening has never been shown to “save lives”-and what we
2. Sackett DL. 2002, The arrogance of preventive medicine. can do about it. BMJ, 352: h6080.
CMAJ, 167(4): 363–364.
https://doi.org/10.1136/bmj.h6080
3. Nyström L, Rutqvist LE, Wall S, et al. 1993, Breast cancer
screening with mammography: Overview of Swedish 13. Gigerenzer G. 2016, Full disclosure about cancer screening.
randomised trials. Lancet, 341(8851): 973–978. BMJ, 352: h6967.
https://doi.org/10.1016/0140-6736(93)91067-v https://doi.org/10.1136/bmj.h6967

Volume 1 Issue 2 (2022) 5 https://doi.org/10.36922/td.v1i2.228